Selected research
Industry Research
Angiography Control Syringe Industry Research Report 2026
Market perspective
The global Angiography Control Syringe market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Angiography Control Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Angiography Control Syringe is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Angiography Control Syringe is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Angiography Control Syringe include Shanghai INT Medical Instruments, Lepu Medical Technology, SCW Medicath, Merit Medical, MedNet, Medline, Edges Medicare, Comed and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Angiography Control Syringe market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Angiography Control Syringe Market by Company
Shanghai INT Medical Instruments
Lepu Medical Technology
SCW Medicath
Merit Medical
MedNet
Medline
Edges Medicare
Comed
Bayer
B.Braun
Argon Medical Devices
Advin Health Care
Jiangxi Hongda Medical Equipment Group
Shenzhen Antmed
BrosMed Medical
Angiography Control Syringe Segment by Type
10ml
12ml
20ml
Others
Angiography Control Syringe Segment by Application
Hospital
Clinic
Others
Angiography Control Syringe Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiography Control Syringe market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Angiography Control Syringe and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiography Control Syringe.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Angiography Control Syringe manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Angiography Control Syringe by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Angiography Control Syringe in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10ml
- 12ml
- 20ml
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Shanghai INT Medical Instruments
- Lepu Medical Technology
- SCW Medicath
- Merit Medical
- MedNet
- Medline
- Edges Medicare
- Comed
- Bayer
- B.Braun
- Argon Medical Devices
- Advin Health Care
- Jiangxi Hongda Medical Equipment Group
- Shenzhen Antmed
- BrosMed Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Angiography Control Syringe Market Size (2021-2032)
- 2.2.2 Global Angiography Control Syringe Sales (2021-2032)
- 2.2.3 Global Angiography Control Syringe Market Average Price (2021-2032)
- 2.3 Angiography Control Syringe by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 10ml
- 2.3.3 12ml
- 2.3.4 20ml
- 2.3.5 Others
- 2.4 Angiography Control Syringe by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Angiography Control Syringe Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Angiography Control Syringe Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Angiography Control Syringe Revenue of Manufacturers (2021-2026)
- 3.4 Global Angiography Control Syringe Average Price by Manufacturers (2021-2026)
- 3.5 Global Angiography Control Syringe Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Angiography Control Syringe, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Angiography Control Syringe, Product Type & Application
- 3.8 Global Manufacturers of Angiography Control Syringe, Established Date
- 3.9 Global Angiography Control Syringe Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shanghai INT Medical Instruments
- 4.1.1 Shanghai INT Medical Instruments Company Information
- 4.1.2 Shanghai INT Medical Instruments Business Overview
- 4.1.3 Shanghai INT Medical Instruments Angiography Control Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shanghai INT Medical Instruments Angiography Control Syringe Product Portfolio
- 4.1.5 Shanghai INT Medical Instruments Recent Developments
- 4.2 Lepu Medical Technology
- 4.2.1 Lepu Medical Technology Company Information
- 4.2.2 Lepu Medical Technology Business Overview
- 4.2.3 Lepu Medical Technology Angiography Control Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Lepu Medical Technology Angiography Control Syringe Product Portfolio
- 4.2.5 Lepu Medical Technology Recent Developments
- 4.3 SCW Medicath
- 4.3.1 SCW Medicath Company Information
- 4.3.2 SCW Medicath Business Overview
- 4.3.3 SCW Medicath Angiography Control Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 SCW Medicath Angiography Control Syringe Product Portfolio
- 4.3.5 SCW Medicath Recent Developments
- 4.4 Merit Medical
- 4.4.1 Merit Medical Company Information
- 4.4.2 Merit Medical Business Overview
- 4.4.3 Merit Medical Angiography Control Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merit Medical Angiography Control Syringe Product Portfolio
- 4.4.5 Merit Medical Recent Developments
- 4.5 MedNet
- 4.5.1 MedNet Company Information
- 4.5.2 MedNet Business Overview
- 4.5.3 MedNet Angiography Control Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 MedNet Angiography Control Syringe Product Portfolio
- 4.5.5 MedNet Recent Developments
- 4.6 Medline
- 4.6.1 Medline Company Information
- 4.6.2 Medline Business Overview
- 4.6.3 Medline Angiography Control Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Medline Angiography Control Syringe Product Portfolio
- 4.6.5 Medline Recent Developments
- 4.7 Edges Medicare
- 4.7.1 Edges Medicare Company Information
- 4.7.2 Edges Medicare Business Overview
- 4.7.3 Edges Medicare Angiography Control Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Edges Medicare Angiography Control Syringe Product Portfolio
- 4.7.5 Edges Medicare Recent Developments
- 4.8 Comed
- 4.8.1 Comed Company Information
- 4.8.2 Comed Business Overview
- 4.8.3 Comed Angiography Control Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Comed Angiography Control Syringe Product Portfolio
- 4.8.5 Comed Recent Developments
- 4.9 Bayer
- 4.9.1 Bayer Company Information
- 4.9.2 Bayer Business Overview
- 4.9.3 Bayer Angiography Control Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bayer Angiography Control Syringe Product Portfolio
- 4.9.5 Bayer Recent Developments
- 4.10 B.Braun
- 4.10.1 B.Braun Company Information
- 4.10.2 B.Braun Business Overview
- 4.10.3 B.Braun Angiography Control Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 B.Braun Angiography Control Syringe Product Portfolio
- 4.10.5 B.Braun Recent Developments
- 4.11 Argon Medical Devices
- 4.11.1 Argon Medical Devices Company Information
- 4.11.2 Argon Medical Devices Business Overview
- 4.11.3 Argon Medical Devices Angiography Control Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Argon Medical Devices Angiography Control Syringe Product Portfolio
- 4.11.5 Argon Medical Devices Recent Developments
- 4.12 Advin Health Care
- 4.12.1 Advin Health Care Company Information
- 4.12.2 Advin Health Care Business Overview
- 4.12.3 Advin Health Care Angiography Control Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Advin Health Care Angiography Control Syringe Product Portfolio
- 4.12.5 Advin Health Care Recent Developments
- 4.13 Jiangxi Hongda Medical Equipment Group
- 4.13.1 Jiangxi Hongda Medical Equipment Group Company Information
- 4.13.2 Jiangxi Hongda Medical Equipment Group Business Overview
- 4.13.3 Jiangxi Hongda Medical Equipment Group Angiography Control Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Jiangxi Hongda Medical Equipment Group Angiography Control Syringe Product Portfolio
- 4.13.5 Jiangxi Hongda Medical Equipment Group Recent Developments
- 4.14 Shenzhen Antmed
- 4.14.1 Shenzhen Antmed Company Information
- 4.14.2 Shenzhen Antmed Business Overview
- 4.14.3 Shenzhen Antmed Angiography Control Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Shenzhen Antmed Angiography Control Syringe Product Portfolio
- 4.14.5 Shenzhen Antmed Recent Developments
- 4.15 BrosMed Medical
- 4.15.1 BrosMed Medical Company Information
- 4.15.2 BrosMed Medical Business Overview
- 4.15.3 BrosMed Medical Angiography Control Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 BrosMed Medical Angiography Control Syringe Product Portfolio
- 4.15.5 BrosMed Medical Recent Developments
5 Global Angiography Control Syringe Market Scenario by Region
- 5.1 Global Angiography Control Syringe Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Angiography Control Syringe Sales by Region: 2021-2032
- 5.2.1 Global Angiography Control Syringe Sales by Region: 2021-2026
- 5.2.2 Global Angiography Control Syringe Sales by Region: 2027-2032
- 5.3 Global Angiography Control Syringe Revenue by Region: 2021-2032
- 5.3.1 Global Angiography Control Syringe Revenue by Region: 2021-2026
- 5.3.2 Global Angiography Control Syringe Revenue by Region: 2027-2032
- 5.4 North America Angiography Control Syringe Market Facts & Figures by Country
- 5.4.1 North America Angiography Control Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Angiography Control Syringe Sales by Country (2021-2032)
- 5.4.3 North America Angiography Control Syringe Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Angiography Control Syringe Market Facts & Figures by Country
- 5.5.1 Europe Angiography Control Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Angiography Control Syringe Sales by Country (2021-2032)
- 5.5.3 Europe Angiography Control Syringe Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Angiography Control Syringe Market Facts & Figures by Country
- 5.6.1 Asia Pacific Angiography Control Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Angiography Control Syringe Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Angiography Control Syringe Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Angiography Control Syringe Market Facts & Figures by Country
- 5.7.1 South America Angiography Control Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Angiography Control Syringe Sales by Country (2021-2032)
- 5.7.3 South America Angiography Control Syringe Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Angiography Control Syringe Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Angiography Control Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Angiography Control Syringe Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Angiography Control Syringe Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Angiography Control Syringe Sales by Type (2021-2032)
- 6.1.1 Global Angiography Control Syringe Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Angiography Control Syringe Sales Market Share by Type (2021-2032)
- 6.2 Global Angiography Control Syringe Revenue by Type (2021-2032)
- 6.2.1 Global Angiography Control Syringe Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Angiography Control Syringe Revenue Market Share by Type (2021-2032)
- 6.3 Global Angiography Control Syringe Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Angiography Control Syringe Sales by Application (2021-2032)
- 7.1.1 Global Angiography Control Syringe Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Angiography Control Syringe Sales Market Share by Application (2021-2032)
- 7.2 Global Angiography Control Syringe Revenue by Application (2021-2032)
- 7.2.1 Global Angiography Control Syringe Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Angiography Control Syringe Revenue Market Share by Application (2021-2032)
- 7.3 Global Angiography Control Syringe Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Angiography Control Syringe Value Chain Analysis
- 8.1.1 Angiography Control Syringe Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Angiography Control Syringe Production Mode & Process
- 8.2 Angiography Control Syringe Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Angiography Control Syringe Distributors
- 8.2.3 Angiography Control Syringe Customers
9 Global Angiography Control Syringe Analyzing Market Dynamics
- 9.1 Angiography Control Syringe Industry Trends
- 9.2 Angiography Control Syringe Industry Drivers
- 9.3 Angiography Control Syringe Industry Opportunities and Challenges
- 9.4 Angiography Control Syringe Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst